Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-03-21
2006-03-21
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
Reexamination Certificate
active
07014861
ABSTRACT:
A composition and a method for increasing the permeability of membrane junctions or cell membranes for delivery of a drug to target tissues are disclosed. Also disclosed are methods and devices for local drug delivery.
REFERENCES:
patent: 2072303 (1937-03-01), Hermann et al.
patent: 4977901 (1990-12-01), Ofstead
patent: 5021044 (1991-06-01), Sharkawy
patent: 5268164 (1993-12-01), Kozarich et al.
patent: 5328471 (1994-07-01), Slepian
patent: 5464650 (1995-11-01), Berg et al.
patent: 5578073 (1996-11-01), Haimovich et al.
patent: 5605696 (1997-02-01), Eury et al.
patent: 5628730 (1997-05-01), Shapland et al.
patent: 5667767 (1997-09-01), Greff et al.
patent: 5670558 (1997-09-01), Onishi et al.
patent: 5686416 (1997-11-01), Kozarich et al.
patent: 5700286 (1997-12-01), Tartaglia et al.
patent: 5716981 (1998-02-01), Hunter et al.
patent: 5800392 (1998-09-01), Racchini
patent: 5824049 (1998-10-01), Ragheb et al.
patent: 5830178 (1998-11-01), Jones et al.
patent: 5830879 (1998-11-01), Isner
patent: 5837313 (1998-11-01), Ding et al.
patent: 5843172 (1998-12-01), Yan
patent: 5851508 (1998-12-01), Greff et al.
patent: 5865814 (1999-02-01), Tuch
patent: 5873904 (1999-02-01), Ragheb et al.
patent: 5971954 (1999-10-01), Conway et al.
patent: 5980928 (1999-11-01), Terry
patent: 5980972 (1999-11-01), Ding
patent: 6010530 (2000-01-01), Goicoechea
patent: 6015541 (2000-01-01), Greff et al.
patent: 6096070 (2000-08-01), Ragheb et al.
patent: 6153252 (2000-11-01), Hossainy et al.
patent: 6165212 (2000-12-01), Dereume et al.
patent: 6689807 (2004-02-01), Walsh
patent: 0 665 023 (1995-08-01), None
patent: 0 970 711 (2000-01-01), None
patent: WO 91/12846 (1991-09-01), None
patent: WO 97/45105 (1997-12-01), None
patent: WO 99/63981 (1999-12-01), None
patent: WO 00/12147 (2000-03-01), None
patent: WO 00/64506 (2000-11-01), None
patent: WO 01/01890 (2001-01-01), None
patent: WO 01/45763 (2001-06-01), None
Alt et al.,Inhibition of Neointima Formation After Experimental Coronary Artery Stenting: A New Biodegradable Stent Coating Releasing Hirudin and the Prostacyclin Analogue Iloprost, Circulation Mar. 28, 2000; 101:1453-1458.
Baldus et al.,Treatment Of Aortocoronary Vein Graft Lesions With Membrane-Covered Stents, Circulation, 2000; 102:2024-2027.
Barath et al.,Low Dose of Antitumor Agents Prevents Smooth Muscle Cell Proliferation After Endothelial Injury, JACC vol. 13, No. 2, Feb. 1989:252A (Abstract).
Christodoulos Stefanadis et al.,Stents Covered By Autologous Venous Grafts: Feasibility And Immediate And Long-Term Results, American Heart Journal, Mar. 2000, vol. 139, No. 3, pp. 437-445.
de Scheerder et al.,Local Methylprednisolone Inhibition Of Foreign Body Response To Coated Intracoronary Stents, Coronary Artery Disease, Feb. 1996, vol. 7, No. 2, pp. 161-166.
Forrester, et al.,A Paradigm for Restenosis Based on Cell Biology: Clues for the Development of New Preventive Therapies, Journal of the American College of Cardiology, Mar. 1, 1991, vol. 17, No. 3, pp. 758-769.
Hurni et al.,Permeability Enhancement in Caco-2 Cell Monolayers by Sodium Salicylate and Sodium Taurodihydrofusidate: Assessment of Effect-Reversibility and Imaging of Transepithelial Transport Routes by Confocal Laser Scanning Microscopy, The Journal of Pharmacology and Experimental Therapeutics vol. 267, No. 2, pp. 942-950 (1993).
Kasirajan et al., Delayed onset of ascending paralysis after thoracic aortic stent graft deployment, Journal of Vascular Surgery, Jan. 2000, vol. 31, No. 1, Part. 1, pp. 196-199.
Matsumaru et al.,Embolic Materials For Endovascular Treatment of Cerebral Lesions; J. Biomater. Sci. Polymer Edn, vol. 8, No. 7 (1997), pp. 555-569.
Miyazaki et al.,Antitumor Effect of Implanted Ethylene-Vinyl Alcohol Copolymer Matrices Containing Anticancer Agents on Ehrlich Ascites Carcinoma and P388 Leukemia in Mice, Chem. Pharm. Bull. 33(6)(1985), pp. 2490-2498.
Miyazawa et al.,Effects of Pemirolast and Tranilast on Intimal Thickening After Arterial Injury in the Rat, J. Cardovasc. Pharmacol. (1997), pp. 157-162.
Monnier et al.,The Use Of The Covered Wallstent For The Palliative Treatment Of Inoperable Tracheobronchial Cancers, Chest, 1996; 110:5:1161-1168.
Nobuyoshi et al.,Restenosis After Percutaneous Transluminal Coronary Angioplast: Pathologic Observations in 20 Patients, Journal of the American College of Cardioloy, Feb. 1991, vol. 17, No. 12, pp. 433-439.
Ohsawa et al.,Preventive Effects of an Antiallergic Drug, Pemirolast Potassium, on Restenosis After Percutaneous Transluminal Coronary Angioplasty; American Heart Journal (Dec. 1998), pp. 1081-1087.
Park et al.,Anti-inflammatory Stent Coatings: Dexamethasone And Related Compounds, Semin. Intervent. Cardiol. 1998; 3:191-195.
Rechavia et al.,Biocompatibility of Polyurethane-Coated Stents: Tissue and Vascular Aspects, Catheterization and Cardiovascular Diagnosis 45:202-207 (1998).
Schellhammer et al.,Polyethylene Terephthalate And Polyurethane Coatings For Endovascular Stents: Preliminary Results In Canine Experimental Arteriovenous Fistulas, Radiology, Apr. 1999, pp. 169-175.
Shigeno,Prevention of Cerebrovascular Spasm by Bosentan, Novel Endothelin Receptor, Chemical Abstract 125:212307 (1996).
van Hoogdalem et al., 3-Amino-1-hydroxypropylidene-1,.1-diphosphonate (APD): A Noval Enhancer Of Rectal Cefoxitin Absorption In Rats, J. Pharm. Pharmacol. 1989, 41:339-341.
van Hoogdalem et al.,Rectal Absorption Enhancement of Cefoxitin and Desglycinamide Arginine Vasopressin by Sodium Tauro-24, 25-Dihydrofusidate in Conscious Rats, The Journal of Pharmacology and Experimental Therapeutics 1989, vol. 251, No. 2, pp. 741-744.
Bhat Vinayak D.
Consigny Paul M.
Roorda Wouter E.
Advanced Cardiovascular Systems Inc.
Azpuru Carlos A.
Squire Sanders & Dempsey L.L.P.
LandOfFree
Permeabilizing reagents to increase drug delivery and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Permeabilizing reagents to increase drug delivery and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Permeabilizing reagents to increase drug delivery and a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549433